- Home
- PRGO vs HTFL Comparison
PRGO vs HTFL Comparison
Compare PRGO & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRGO
- HTFL
- Stock Information
- Founded
- PRGO 1887
- HTFL 2007
- Country
- PRGO Ireland
- HTFL United States
- Employees
- PRGO N/A
- HTFL N/A
- Industry
- PRGO Biotechnology: Pharmaceutical Preparations
- HTFL
- Sector
- PRGO Health Care
- HTFL
- Exchange
- PRGO Nasdaq
- HTFL Nasdaq
- Market Cap
- PRGO 3.2B
- HTFL 2.6B
- IPO Year
- PRGO 1991
- HTFL 2025
- Fundamental
- Price
- PRGO $23.70
- HTFL $31.50
- Analyst Decision
- PRGO Buy
- HTFL
- Analyst Count
- PRGO 4
- HTFL 0
- Target Price
- PRGO $33.00
- HTFL N/A
- AVG Volume (30 Days)
- PRGO 2.0M
- HTFL 1.0M
- Earning Date
- PRGO 08-06-2025
- HTFL 01-01-0001
- Dividend Yield
- PRGO 4.88%
- HTFL N/A
- EPS Growth
- PRGO N/A
- HTFL N/A
- EPS
- PRGO N/A
- HTFL N/A
- Revenue
- PRGO $4,326,100,000.00
- HTFL $136,170,000.00
- Revenue This Year
- PRGO $2.28
- HTFL N/A
- Revenue Next Year
- PRGO $0.54
- HTFL N/A
- P/E Ratio
- PRGO N/A
- HTFL N/A
- Revenue Growth
- PRGO N/A
- HTFL 44.32
- 52 Week Low
- PRGO $21.03
- HTFL $26.56
- 52 Week High
- PRGO $30.93
- HTFL $36.68
- Technical
- Relative Strength Index (RSI)
- PRGO 41.75
- HTFL N/A
- Support Level
- PRGO $23.61
- HTFL N/A
- Resistance Level
- PRGO $24.04
- HTFL N/A
- Average True Range (ATR)
- PRGO 0.59
- HTFL 0.00
- MACD
- PRGO 0.15
- HTFL 0.00
- Stochastic Oscillator
- PRGO 60.19
- HTFL 0.00
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
About HTFL Heartflow Inc. Common Stock
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.